1-4 of 4
Ashutosh S. Jogalekar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity

Elena S. Koltun, Naing Aay, Andreas Buckl, Ashutosh S. Jogalekar, Gert Kiss, Abby Marquez, Kevin T. Mellem, Kasia Mordec, Mae Saldajeno-Concar, Chris M. Semko, Nidhi Tibrewal, Christos Tzitzilonis, Walter Won, Jacqueline A. Smith, Susan E. Wilson, Robert J. Nichols, Zhengping Wang, David Wilds, Mallika Singh, Adrian L. Gill
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4878.
https://doi.org/10.1158/1538-7445.AM2018-4878
Published: 01 July 2018
View article titled, Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity
Journal Articles

Abstract 4877: Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations

David Wildes, Naing Aay, Andreas Buckl, Daphne Hsieh, Ashutosh S. Jogalekar, Gert Kiss, Elena S. Koltun, Abby Marquez, Kevin T. Mellem, Jason Romero, Mae Saldajeno-Concar, Christopher J. Schulze, Chris M. Semko, Walter Won, Robert J. Nichols, Carlos Stahlhut, Christos Tzitzilonis, Adrian L. Gill, Jacqueline A. Smith
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4877.
https://doi.org/10.1158/1538-7445.AM2018-4877
Published: 01 July 2018
View article titled, Abstract 4877: Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations
Journal Articles

The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity

Simak Ali, Dean A. Heathcote, Sebastian H.B. Kroll, Ashutosh S. Jogalekar, Bodo Scheiper, Hetal Patel, Jan Brackow, Alekasandra Siwicka, Matthew J. Fuchter, Manikandan Periyasamy, Robert S. Tolhurst, Seshu K. Kanneganti, James P. Snyder, Dennis C. Liotta, Eric O. Aboagye, Anthony G.M. Barrett, R. Charles Coombes
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6208–6215.
https://doi.org/10.1158/0008-5472.CAN-09-0301
Published: 29 July 2009
View article titled, The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
Open the PDF for The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity in another window
Includes: Supplementary data
Journal Articles

Abstract #3311: The development of a selective CDK7 inhibitor with anti-tumor activity

Raoul Coombes, cheiper, Ashutosh S. Jogalekar, Jan Brackow Simak Ali, Dean Heathcote, Sebastian Kroll, Bodo S, Aleksandra Siwicka, Manikandan Periyasamy, Robert Tolhurst, Seshu Kanneganti, James Snyder, Dennis Liotta, Eric Aboagye, Anthony Barrett
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3311.
Published: 01 May 2009
View article titled, Abstract #3311: The development of a selective CDK7 inhibitor with anti-tumor activity